Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERN1 | O75460 | 1/20 | 0.33 |
| ▸ | CTSL | P07711 | 1/20 | 0.32 |
| ▸ | CTSS | P25774 | 1/20 | 0.32 |
| ▸ | CTSK | P43235 | 1/20 | 0.32 |
| ▸ | TUBB1 | Q9H4B7 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16553559 | 0.78 | ERN1 (0.36) | ERN1TUBB1 | |
| SCHEMBL28093668 | 0.74 | ERN1 (0.36) | ERN1 | |
| SCHEMBL17861606 | 0.69 | TUBB1 (0.38) | CTSSCTSKTUBB1 | |
| SCHEMBL26586914 | 0.69 | — | — | |
| SCHEMBL14407366 | 0.67 | L3MBTL1 (0.34) | — | |
| SCHEMBL24933380 | 0.63 | APP (0.50) | — | |
| SCHEMBL14291570 | 0.61 | APP (0.39) | — | |
| SCHEMBL29425553 | 0.61 | ERN1 (0.61) | ERN1 | |
| SCHEMBL6900249 | 0.61 | ERN1 (0.61) | ERN1 | |
| Formaldehyde SCHEMBL28061059 | 0.61 | TTR (0.45) | ERN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11957755-B2 | Radiopaque polymers | Boston Scientific Medical Device Limited (IE) | 2024-04-16 | — | — | US | disclosed |
| US-20230355833-A1 | RADIOPAQUE POLYMERS | BIOCOMPATIBLES UK LIMITED (GB) | 2023-11-09 | — | — | US | disclosed |
| CN-111518285-B | Imageable polymers | 生物兼容英国有限公司 | 2023-09-22 | — | — | CN | disclosed |
| US-11744916-B2 | Radiopaque polymers | BIOCOMPATIBLES UK LIMITED | 2023-09-05 | — | — | US | disclosed |
| EP-3492110-B1 | RADIOPAQUE POLYMERS | BIOCOMPATIBLES UK LTD (GB) | 2023-03-08 | — | — | EP | disclosed |
| CN-110950981-B | Radiopaque polymers | 生物兼容英国有限公司 | 2023-02-17 | — | — | CN | disclosed |
| CN-111494699-B | Radiopaque polymers | 生物兼容英国有限公司 | 2022-05-31 | — | — | CN | disclosed |
| EP-3999559-A1 | RADIOPAQUE POLYMERS | Biocompatibles UK Limited (GB) | 2022-05-25 | — | — | EP | disclosed |
| EP-4000639-A1 | IMAGEABLE POLYMERS | Biocompatibles Uk Ltd. (GB) | 2022-05-25 | — | — | EP | disclosed |
| CN-114127134-A | Radiopaque polymers | 生物相容英国有限公司 | 2022-03-01 | — | — | CN | disclosed |
| US-10098972-B2 | Imageable polymers | BIOCOMPATIBLES UK LTD. (GB) | 2018-10-16 | — | — | US | disclosed |
| US-9895452-B2 | Imageable polymers | BIOCOMPATIBLES UK LIMITED (GB) | 2018-02-20 | — | — | US | disclosed |
| US-20160228556-A1 | Radiopaque Polymers | Boston Scientific Medical Device Limited (IE) | 2016-08-11 | — | — | US | disclosed |
| EP-3041515-A1 | RADIOPAQUE POLYMERS | Biocompatibles Uk Ltd. (GB) | 2016-07-13 | — | — | EP | disclosed |
| EP-3041516-A1 | IMAGEABLE POLYMERS | Biocompatibles Uk Ltd. (GB) | 2016-07-13 | — | — | EP | disclosed |
| US-20160193367-A1 | Imageable Polymers | BIOCOMPATIBLES UK LTD (GB) | 2016-07-07 | — | — | US | disclosed |
| WO-2015033093-A9 | RADIOPAQUE POLYMERS | BIOCOMPATIBLES UK LTD (GB) | 2016-04-07 | — | — | WO | disclosed |
| US-20150110722-A1 | IMAGEABLE POLYMERS | Boston Scientific Medical Device Limited (IE) | 2015-04-23 | — | — | US | disclosed |
| WO-2015033093-A1 | RADIOPAQUE POLYMERS | BIOCOMPATIBLES UK LTD (GB) | 2015-03-12 | — | — | WO | disclosed |
| WO-2015033092-A1 | IMAGEABLE POLYMERS | BIOCOMPATIBLES UK LTD (GB) | 2015-03-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160228556-A1 | Radiopaque Polymers | RAD51, RXFP3, RXFP1 | ERN1 3995/4885CTSL 4192/4885CTSS 3171/4885 |
| US-10098972-B2 | Imageable polymers | VHL, FLT4, FLT1 | ERN1 1786/4885CTSL 3024/4885CTSS 3716/4885 |
| US-20150110722-A1 | IMAGEABLE POLYMERS | BRDT, BRD3, BRD2 | ERN1 3538/4885CTSL 4297/4885CTSS 2729/4885 |
| US-20230355833-A1 | RADIOPAQUE POLYMERS | TPO, PGLS, IQGAP1 | ERN1 3496/4885CTSL 2742/4885CTSS 4209/4885 |
| US-11957755-B2 | Radiopaque polymers | RXFP3, RXFP1, DAGLA | ERN1 3490/4885CTSL 4459/4885CTSS 4277/4885 |
| US-20160193367-A1 | Imageable Polymers | VHL, FLT4, FLT1 | ERN1 1786/4885CTSL 3024/4885CTSS 3716/4885 |
| US-11744916-B2 | Radiopaque polymers | TPO, PGLS, IQGAP1 | ERN1 3496/4885CTSL 2742/4885CTSS 4209/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.